Publication | Closed Access

A phase I trial of high-dose paclitaxel, cyclophosphamide and mitoxantrone with autologous blood stem cell support for the treatment of metastatic breast cancer

Metastatic Breast CancerOncologyBreast OncologyMedicineBreast CancerPharmacotherapyHigh-dose PaclitaxelCancer TreatmentPharmacology